Trial intelligence / Profile preview

BUCCALIN prophylaxis trial for recurrent respiratory tract infections

2011-005187-25Phase 4Completed

Sponsor
Laboratorio Farmaceutico SIT
Start
Mar 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Buccalin in Airways Infection, upper respiratory infection (URI), pulmonary infection, bacterial airway infections, sponsored by Laboratorio Farmaceutico SIT. Started Mar 2012; status: completed.

02

Drugs

Buccalin
03

Conditions

Airways Infectionupper respiratory infection (URI)pulmonary infectionbacterial airway infections

Beyond the preview

Go deeper on 2011-005187-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005187-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call